Nina Shah, MD, on Newly Diagnosed Multiple Myeloma: Novel Combination Therapies

August 16, 2021 By The ASCO Post Staff

Nina Shah, MD, of the University of California, San Francisco, discusses triplet drug combinations that are the current standard of care for transplant-eligible and -ineligible patients with multiple myeloma, as well as quadruplet therapies that demonstrate depth of response in newly diagnosed cases, where they may become the standard of care along with transplantation and maintenance treatments.

Related Content